A detailed history of Nomura Holdings Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 18,299 shares of HRMY stock, worth $603,867. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,299
Previous 70,204 73.93%
Holding current value
$603,867
Previous $2.12 Million 65.49%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.0 - $39.95 $1.56 Million - $2.07 Million
-51,905 Reduced 73.93%
18,299 $731,000
Q2 2024

Aug 14, 2024

SELL
$28.81 - $33.01 $51,166 - $58,625
-1,776 Reduced 2.47%
70,204 $2.12 Million
Q1 2024

May 15, 2024

BUY
$29.93 - $35.06 $2.15 Million - $2.52 Million
71,980 New
71,980 $2.42 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.95B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.